glp-1 and eye disease GLP 1 Blindness Risk GLP-1s and Eye Health: What

As HF management continues to evolve, GLP1-RAs emerge as a promising yet complex therapeutic option

Direct demonstration of brain insulin resistance in Alzheimers and Parkinsons disease dementia and its alleviation with incretin receptor agonists

These drugs are labeled For Research Use Only (RUO) or Not for Human Consumption

Suppressed macrophage infiltration followed by reduced macrophage foam cell formation by active forms of GLP-1 and GIP was demonstrated by Nagashima M, et al

Cocaine Only limited clinical evidence is available for GLP-1RAs in cocaine misuse: a small ( N = 13) proof-of-concept trial across 2 days showed that exenatide compared with placebo did not reduce the number of self-administered cocaine infusions 115 , while a case series of 3 individuals with cocaine-use disorder highlighted the feasibility and safety of using the same drug over 6 weeks, although no efficacy measures were reported 116